Balkan endemic nephropathy and genetic variants of glutathione S-transferases

Journal of Nephrology

Volumn 17, Issue 3, 2004, Pages 390-398

  Andonova, Irena E ^a   Sarueva, Radoslava B ^a   Horvath, Anelia D ^a   Simeonov, Valery A ^b   Dimitrov, Plamen S ^a   Petropoulos, Evangelos A ^c   Ganev, Varban S ^a,c  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b Vratza District Hospital   (Bulgaria)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Balkan endemic nephropathy; Genetic polymorphism; Glutathione S transferases; Nephrotoxicity

Indexed keywords

GLUTATHIONE TRANSFERASE;

ADULT; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DNA EXTRACTION; ENZYME POLYMORPHISM; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INTERSTITIAL NEPHRITIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL SIGNIFICANCE; VENOUS BLOOD; WILD TYPE;

ACYLTRANSFERASES; AGED; BALKAN NEPHROPATHY; FEMALE; GENE FREQUENCY; GENETIC HETEROGENEITY; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 4243052782     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Polenakovic, MH, Stefanovic, V. Balkan nephropathy. In Davison AM, Cameron JS, Grunfeld JP, Kerr DNS, Ritz E, Winearls, CG Eds. Oxford textbook of clinical nephropathy, 2nd edn, vol 2. Oxford: Oxford University Press 1977; 1203-11.
2. Radonic M, Radosevic Z. Clinical features of Balkan endemic nephropathy. Food Chem Toxicol 1992; 30: 189-92.
3. Bozic Z, Duancic V, Belicza M, Kraus O, Skljarov I. Balkan endemic nephropathy: still a mysterious disease. Eur J Epidemiol 1995; 11: 235-8.
4. Wedeen RP. Environmental renal-disease - lead, cadmium and Balkan endemic nephropathy. Kidney Int Suppl 1991; 34: S4-8.
5. Ganev VS, Petropoulos EA. Balkan endemic nephropatby and its putative environmental and genetic causes: A review the 6th International Conference on Environmental Science and Technology, Pythagorion, Samos, Greece 1999; 11-21.
6. Radovanovic Z, Stefanovic D. Different forms of mineral nitrogen in drinking water and Balkan nephropathy. Arch Environ Contam Toxicol 1988; 17: 813-5.
7. Feder GL, Radovanovic Z, Finkelman RB. Relationship between weathered coal deposits and the etiology of Balkan endemic nephropathy. Kidney Int Suppl 1991; 34: S9-11.
8. Cosyns JP, Jadoul M, Squifflet JP. Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? Kidney Int 1994; 45: 1680-8.
9. Dimitrov M, ed. Medizina i Fizkultura, Sofia (in Bulgarian) 1960.
10. Eaton DL. Biotransformation enzyme polymorphism and pesticide susceptibility. Neurotoxicology 2000; 21: 101-11.
11. Eaton DL, Bammler TK. Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol Sci 1999; 49: 156-64.
12. Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res 2000; 463: 247-83.
13. Wang L, Groves MJ, Hepburn MD, Bowen DT. Glutathione S-transferase enzyme expression in hematopoietic cell lines implies a differential protective role for T1 and A1 isoenzymes in erythroid and for M1 in lymphoid lineages. Haematologica 2000; 85: 573-9.
14. El Adlouni C, Pinelli E, Azemar B, Zaoui D, Beaune P, Pfohl-Leszkowicz A. Phenobarbital increases DNA adduct and metabolites formed by ochratoxin A: role of CYP 2C9 and microsomal glutathione-S-transferase. Environ Mol Mutagen 2000; 35: 123-31.
15. Mannervik B, Awasthi YC, Board PG, Hayes JD, Di Ilio C, Ketterer B, Listowsky I, Morgenstern R, Muramatsu M, Pearson WR, Pickett CB, Sato K, Widersten M, Wolf CR. Nomenclature for human glutathione transferases. Biochem J 1992; 282: 305-6.
16. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995; 30: 445-600.
17. Seidegard J, Vorachek WR, Pero RW, Pearson WR. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 1988; 85: 7293-7.
18. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B, Taylor JB. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994; 300: 271-6.
19. Ali-Osman F, Akande O, Antoun G, Mao JX, Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants: evidence for differential catalytic activity of the encoded proteins. J Biol Chem 1997; 272: 10004-12.
20. Norppa H. Genetic polymorphisms and chromosome damage. Int J Hyg Environ Health 2001; 204: 31-8.
21. Zimniak P, Nanduri B, Pikula S, Bandorowicz-Pikula J, Singhal SS, Srivastava SK, Awasthi S, Awasthi YC. Naturally occurring human glutathione S-transferase GSTPI-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. Eur J Biochem 1994; 224: 893-9.
22. Watson MA, Stewart RK, Smith GB, Massey TE, Bell DA. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 1998; 19: 275-80.
23. Gronau S, Konig-Greger D, Rettinger G, Riechelmann H. GSTM1 gene polymorphism in patients with head and neck tumors. Laryngorhinootologie 2000; 79: 341-4.
24. Katoh T. Application of molecular biology to occupational health field - the frequency of gene polymorphism of cytochrome P450 1A1 and glutathione S-transferase M1 in patients with lung, oral and urothelial cancer. J UOEH 1995; 17: 271-8.
25. Aktas D, Ozen H, Atsu N, Tekin A, Sozen S, Tuncbilek E. Glutathione S-transferase M1 gene polymorphism in bladder cancer patients. A marker for invasive bladder cancer? Cancer Genet Cytogenet 2001; 125: 1-4.
26. Gawronska-Szklarz B, Lubinski J, Kladny J, Kurzawski G, Bielicki D, Wojcicki M, Sych Z, Musial HD. Polymorphism of GSTM1 gene in patients with colorectal cancer and colonic polyps. Exp Toxicol Pathol 1999; 51: 321-5.
27. van Lieshout EM, Roelofs HM, Dekker S, Mulder CJ, Wobbes T, Jansen JB, Peters WH. Polymorphic expression of the glutathione S-transferase P1 gene and its susceptibility to Barrett's esophagus and esophageal carcinoma. Cancer Res 1999; 59: 586-9.
28. Mann CL, Davies MB, Boggild MD, Alldersea J, Fryer AA, Jones PW, Ko Ko C, Young C, Strange RC, Hawkins CP. Glutathione S-transferase polymorphisms in MS: their relationship to disability. Neurology 2000; 54: 552-7.
29. Stroombergen MC, Waring RH. Determination of glutathione S-transferase mu and theta polymorphisms in neurological disease. Hum Exp Toxicol 1999; 18: 141-5.
30. Menegon A, Board PG, Blackburn AC, Mellick GD, Le Couteur DG. Parkinson's disease, pesticides, and glutathione transferase polymorphisms. Lancet 1998; 352: 1344-6.
31. Allan JM, Wild CP, Rollinson S, Willett EV, Moorman AV, Dovey GJ, Roddam PL, Roman E, Cartwright RA, Morgan GJ. Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. Proc Natl Acad Sci USA 2001; 98: 11592-7.
32. Stanulla M, Schrappe M, Brechlin AM, Zimmermann M, Welte K. Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study. Blood 2000; 95: 1222-8.
33. Basu T, Gale RE, Langabeer S, Linch DC. Glutathione S-transferase theta 1 (GSTT1) gene defect in myelodysplasia and acute myeloid leukaemia. Lancet 1997; 349: 1450.
34. Longuemaux S, Delomenie C, Gallon C, Mejean A, Vincent-Viry M, Bouvier R, Droz D, Krishnamoorthy R, Galteau MM, Junien C, Beroud C, Dupret JM. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes. Cancer Res 1999; 59: 2903-8.
35. Steinhoff C, Franke KH, Golka K, Thier R, Romer HC, Rotzel C, Ackermann R, Schulz WA. Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma. Arch Toxicol 2000; 74: 521-6.
36. Gsur A, Haidinger G, Hinteregger S, Bernhofer G, Schatzl G, Madersbacher S, Marberger M, Vutuc C, Micksche M. Polymorphisms of glutathione-S-transferase genes (GSTP1, GSTM1 and GSTT1) and prostate-cancer risk. Int J Cancer 2001; 95: 152-5.
37. Bailey LR, Roodi N, Verrier CS, Yee CJ, Dupont WD, Parl FF. Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. Cancer Res 1998; 58: 65-70.
38. Ishii T, Matsuse T, Teramoto S, Matsui H, Miyao M, Hosoi T, Takahashi H, Fukuchi Y, Ouchi Y. Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease. Thorax 1999;54: 693-6.
39. Hemmingsen A, Fryer AA, Hepple M, Strange RC, Spiteri MA. Simultaneous identification of GSTP1 Ile105 ->Val 105 and Ala114 -> Vall14 substitutions using an amplification refractory mutation system polymerase chain reaction assay: studies in patients with asthma. Respir Res 2001; 2: 255-60.
40. Verlaan M, te Morsche RHM, Roelofs HMJ, Laheij RJF, Jansen JBMJ, Peters WHM, Drenth JPH. Glutathione S-transferase Mu null genotype affords protection against alcohol induced chronic pancreatitis. Am J Med Genet 2003; 120A: 34-9.
41. Carless MA, Lea RA, Curran JE, Appleyard B, Gaffney P, Green A, Griffiths LR. The GSTM1 null genotype confers an increased risk for solar keratosis development in an Australian Caucasian population. J Invest Dermatol 2002; 119: 1373-8.
42. Hersberger M, Marti-Jaun J, Rentsch K, Hanseler E. Rapid detection of the CYP2D6*3, CYP2D6*4, and CYP2D6*6 alleles by tetra-primer PCR and of the CYP2D6*5 allele by multiplex long PCR. Clin Chern 2000; 46: 1072-7.
43. Sarmanova J, Tynkova L, Susova S, Gut I, Soucek P. Genetic polymorphisms of biotransformation enzymes: allele frequencies in the population of the Czech Republic. Pharmacogenetics 2000; 10: 781-8.
44. Rebbeck T. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997; 6: 733-43.
45. Abouzied M, Horvath A, Podlesny P, Regina N, Metodiev V, Kamenova-Tozeva R, Niagolova N, Stein A, Petropoulos E, Ganev V. Ochratoxin A concentrations in food and feed from a region with Balkan endemic nephropathy. Food Addit Contam 2002; 19: 755-64.
46. Long D, Icopini G, Ganev V, Petropoulos A, Havezov I, Voice T, Chou K, Spassov A, Stein A. Geochemistry of Bulgarian soils in villages affected and not affected by Balkan endemic nephropathy: A pilot study. Int J Occup Med Environ Health 2001; 14: 193-6.
47. Anders MW, Lash L, Dekant W, Elfarra AA, Dohn DR. Biosynthesis and biotransformation of glutathione S-conjugates to toxic metabolites. Crit Rev Toxicol 1988; 18: 311-41.
48. Koob M, Dekant W. Bioactivation of xenobiotics by formation of toxic glutathione conjugates. Chem Biol Interact 1991; 77: 107-36.
49. Anders MW, Dekant W, Vamvakas S. Glutathione-dependent toxicity. Xenobiotica 1992; 22: 1135-45.
50. Anders MW, Dekant W. Renal xenobiotic metabolism: role in bioactivation of nephrotoxic xenobiotics. In Anders MW, Dekant W, Henschler D, Oberleithner H, Silbernagl S Eds. Renal disposition and nephrotoxicity of xenobiotics. San Diego: Academic Press, 1993; 155-83.
51. van Bladeren PJ. Glutathione conjugation as a bioactivation reaction. Chem Biol Interact 2000; 129: 61-76.
52. Dekant W. Chemical-induced nephrotoxicity mediated by glutathione S-conjugate formation. Toxicol Lett 2001; 124: 21-36.
53. Delbanco EH, Bolt HM, Huber WW, Beken S, Geller F, Philippou S, Brands FH, Bruning T, Thier R. Glutathione transferase activities in renal carcinomas and adjacent normal renal tissues: factors influencing renal carcinogenesis induced by xenobiotics. Arch Toxicol 2001; 74: 688-94.
54. van Iersel ML, Verhagen H, van Bladeren PJ: The role of biotransformation in dietary (anti) carcinogenesis. Mutat Res 1999; 443: 259-70.
55. Rock CL, Lampe JW, Patterson RE. Nutrition, genetics, and risks of cancer. Annu Rev Public Health 2000; 21: 47-64.
56. Steinkellner H, Rabot S, Freywald C, Nobis E, Scharf G, Chabicovsky M, Knasmuller S, Kassie F. Effects of cruciferous vegetables and their constituents on drug metabolizing enzymes involved in the bioactivation of DNA-reactive dietary carcinogens. Mutat Res 2001; 480: 285-97.
57. Schaaf GJ, Nijmeijer SM, Maas RF, Roestenberg P, de Groene EM, Fink-Gremmels J. The role of oxidative stress in the ochratoxin A-mediated toxicity in proximal tubular cells. Biochim Biophys Acta 2002; 1588: 149-58.
58. El Adlouni C, Pinelli E, Azemar B, Zaoui D, Beaune P, Pfohl-Leszkowicz A. Phenobarbital increases DNA adduct and metabolites formed by ochratoxin A: role of CYP 2C9 and microsomal glutathione-S-transferase. Environ Mol Mutagen 2000; 35: 123-31.
59. Toncheva D, Dimitrov Tz, Tzoneva M. Cytogenetic studies in Balkan endemic nephropathy. Nephron 1988; 48: 18-21.
60. Manolov G, Manolova Y, Castegnaro M, Chernozemsky IN. Chromosomal alterations in lymphocytes of patients with Balkan endemic nephropathy and of healthy individuals after incubation in vitro with ochratoxin A. IARC Sci Publ 1991; 115: 267-72.
61. Toncheva DI, Atanassova SY, Gergov TD, Todorovska EG, Roeva IG, Georgiev TH, Fink-Gremmels J, Zaharieva BM. Genetic changes in uroepithelial tumors of patients with Balkan endemic nephropathy. J Nephrol 2002; 15: 387-93.